Market Research Logo

Vaccines 2011-15: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry


Attention: There is an updated edition available for this report.

The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2010 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions.

Kalorama Information has been closely following vaccine markets and has instituted a yearly market research report schedule since 2003 in order to keep up with fast-moving developments. Our latest comprehensive update, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines the market for vaccines used in humans for various diseases. This state-of-the-industry report is a must-have for any executive who wants to stay on top of a rapidly changing market and see what’s expected down the road based on analysis of major company pipelines.

The report covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable.

Trends discussed in this report include the introduction of needle-free systems and the production of vaccines, as well as product safety, supply shortages, and the use of vaccines to prevent pandemics and address bioterrorism, DNA vaccinations, and innovations in vaccine delivery systems. News and reports of vaccine-related illness tend to exacerbate the public’s fears and result in higher rates of non-immunization, another issue which is discussed in this edition of the report.

Included in this report are current market size and forecast for the following vaccines:

Pediatric Vaccines:

  • Combinations
  • Hepatitis
  • HIB
  • MMR
  • Pneumococcal
  • Poliovirus
  • Varicella
  • Other Pediatric
Adult Vaccines:
  • Cervical Cancer
  • Hepatitis
  • Influenza
  • Pneumococcal
  • Travel; DT; Misc.

Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions:

  • U.S.
  • Rest of North Amer.
  • South America
  • Europe
  • Japan
  • India
  • China
  • Rest of World
In addition, the report profiles key competitors in the vaccine industry. Companies profiled in the report include:
  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Celldex Therapeutics
  • Crucell / Johnson and Johnson
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Nabi Biopharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi Pasteur

Revenue estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends... these form the basis of the forecasting and competitive analysis.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/


Continued Climb for Pharma Vaccine Revenues

In an industry facing patent expirations and layoffs, vaccine products continue to offer good news, according to healthcare market research publisher Kalorama Information. The world market for preventative vaccines totaled $25.3 billion in 2010, up from $22.1 billion in 2009, according to its annual report on the industry, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The report notes that the worldwide vaccine market is predicted to increase at a compound annual rate of 9.3% during the next five years, as new product introductions continue and the products are sold to emerging markets.

"Vaccines are a priority at the major companies and there has been no let-up in the business in the four years that we have been tracking it annually," said Bruce Carlson, publisher of Kalorama Information. "We continue to see over nine percent growth in sales, and in some emerging markets the rate of growth is even faster. There is also a strong pipeline that should sustain growth as new products are launched."

The healthcare market research firm indicated that sales to Latin America, India and China will grow at double-digit rates.

Vaccines are commonly segmented into two target markets, adult and pediatric. According to Kalorama Information, the pediatric vaccine market is larger, accounting for more than half of the total market. Pediatric vaccines are also growing at a faster rate than adult vaccines and this is expected to continue over the next five years. Pneumococcal and "combination" DTaP vaccines continue to drive growth in the pediatric sector, while influenza and hepatitis vaccine products are driving sales in the adult segment of the market.

The world vaccines market is dominated by five major competitors: Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Together, they held four-fifths of the market in 2010. All but Pfizer and Merck posted strong double-digit growth in their vaccine businesses. Sanofi Pasteur, a subsidiary of Sanofi Aventis, was the leading manufacturer, according to Kalorama Information, with GlaxoSmithKline a close second. The company's position was largely due to its influenza products, although its polio/pertussis/Hib products also account for a significant portion of its vaccine sales.

More information is available from Kalorama Information's report, Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry, including market forecasts, company profiles, and trends in the industry.

  • Executive Summary
    • THE GLOBAL VACCINES INDUSTRY
      • Scope and Methodology
      • Overview
      • Pediatric Preventative Vaccines
    • THE MARKET
    • TOTAL MARKET
    • ISSUES AND TRENDS
  • Introduction to Vaccines
    • Table Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2010
    • A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES
    • THE IMMUNE RESPONSE
    • MECHANISM OF ACTION
    • TYPES OF VACCINES
      • Attenuated (Weakened) Live Viruses
        • Table Vaccine-Preventable Diseases, June 2011
      • Killed (Inactivated) Viruses
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
      • Subunit Vaccines
      • Conjugate Vaccines
      • DNA Vaccination
      • VACCINE APPROVAL PROCESS
        • Table VAERS Table of Reportable Events Following Vaccination
  • Pediatric Preventive Vaccines
    • INTRODUCTION
      • Table Global Immunization Rates by Vaccine Type (DPT3, BCG, HepB, Yellow Fever, Tetanus, Hib, MCV, Polio) 2009
    • CHILDHOOD IMMUNIZATION IN THE UNITED STATES
      • Childhood Immunization Rates
        • Table Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2009
      • Challenges to the Vaccine Delivery System
      • The Effect of U.S. Healthcare Reform
      • Recommended Childhood Immunization Schedule
        • Table U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2011
        • Table U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2011
      • State Immunization Recommendations
      • United Nations Initiatives
    • PEDIATRIC VACCINE PRODUCTS
      • BCG
      • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Diphtheria
      • Pertussis
      • Tetanus
      • Hepatitis B
      • Poliomyelitis
      • Enterotoxigenic Escherichia coli
      • Haemophilus Influenzae Type B
      • Hepatitis A
      • Measles, Mumps and Rubella
      • Measles
      • Mumps
      • Rubella
      • Meningococcal Disease
      • Parainfluenza Virus Type 3
      • Pneumococcal Conjugate
      • Rotavirus
      • Respiratory Syncytial Virus
      • Varicella
    • PEDIATRIC VACCINES IN DEVELOPMENT
    • COST OF VACCINES IN THE UNITED STATES
      • Table Selected Pediatric Vaccines in Development, June 2011
    • THE WORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Pediatric Vaccines 2006-2015 Revenues (in millions)
        • Table World Market for Pediatric Vaccines by Region (U.S., Rest of North Amer, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions)
      • Hepatitis Vaccine Market
        • Table World Pediatric Hepatitis Vaccine Market 2006-2015
      • Haemophilus Influenzae Type B Vaccine Market
        • Table World Hib Vaccine Market, 2006-2015
      • Measles, Mumps and Rubella Vaccines
        • Table World MMR Vaccines Market 2006-2015
      • Combination Vaccines Market
        • Table World Combination Vaccines Market 2006-2015
      • Pneumococcal Vaccine
        • Table World Pediatric Pneumococcal Vaccine Market 2006-2015
      • Poliovirus Vaccine
        • Table World Poliovirus Vaccine Market 2006-2015
      • Varicella Vaccines
        • Table World Varicella Vaccine Market 2006-2015
      • Other Vaccines Market
        • Table World Pediatric Other Vaccines Market 2006-2015
  • Adult Preventive Vaccines
    • INTRODUCTION
    • ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES
    • GLOBAL INFLUENZA SURVEILLANCE PROGRAM
      • U.S. Surveillance
    • RECOMMENDATIONS FOR ADULT IMMUNIZATIONS
      • Table Universal Adult Immunization Schedule 2011
      • Table Adult Immunization Schedule for Populations with Special Medical Conditions, 2011
      • WHO International Health Regulations
    • ADULT VACCINE PRODUCTS
      • Allergies
      • Cervical Cancer
        • Table Initiatives to Require HPV Vaccination by U.S. State, 2011
      • Cholera
      • Dengue Fever
      • Diphtheria-Tetanus
      • Hepatitis
      • Hepatitis A
      • Hepatitis B
      • Influenza
        • Table WHO Pandemic Classification Schedule
      • Japanese Encephalitis
      • Malaria
      • Pneumococcal Disease
      • Rabies
      • Shingles
      • Typhoid Fever
      • Yellow Fever
    • ADULT VACCINES IN DEVELOPMENT
      • Table Selected Adult Preventive Vaccines in Development, 2011
    • TOTAL MARKET SIZE AND FORECAST
      • Table World Market for Adult Preventive Vaccines, 2006-2015 Revenues (in millions)
      • Table World Market for Adult Vaccines by Region (U.S., Rest of North Amer., South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions)
      • Cervical Cancer Market
        • Table World Cervical CancerVaccine Market 2006-2015
      • Hepatitis Market
        • Table World Hepatitis Vaccine Market 2006-2015
      • Influenza Vaccine Market
        • Table World Influenza Vaccine Market 2006-2015
        • Table 2010 Estimated Population by Region (Africa, Asia, Europe, N. America, Oceania, South America) and Selected Age Group (in millions)
        • Table World Pneumococcal Vaccine Market 2006-2015
      • Travel, DT, and Miscellaneous Vaccine Market
        • Table World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2006-2015
  • Vaccines Market Summary
    • TRENDS DRIVING THE VACCINES MARKET
    • MARKET SIZE AND FORECAST
      • Table The World Vaccines Market, Adult and Pediatric, 2006-2015 Revenues (in millions)
      • Vaccine Sales by Region
      • Vaccine Market Competitors
        • Table The World Vaccines Market by Region (U.S, Rest of North Amer., South America, EU, Japan, India, China, ROW) 2006-2015 Revenues (in millions)
        • Table Major Manufacturers' Shares of the World Vaccine Market, 2010
      • Pediatric Vaccines
        • Table Major Manufacturer's Shares of the World Pediatric Vaccine Market 2010
      • Adult Vaccines
        • Table Major Manufacturer's Shares of the World Adult Vaccine Market 2010
  • Issues and Trends
    • VACCINE SAFETY
      • Refusal to Immunize
      • Obesity
      • Post-Licensure Surveillance
      • Vaccine Adverse Event Reporting System
      • The Vaccine Safety Datalink Project
      • Phase IV studies
      • The Vaccine Injury Compensation Program
      • Countermeasures Injury Compensation Program
      • World Health Organization
      • Other Initiatives
      • The Future of Vaccine Safety
    • VACCINE SHORTAGES
      • Preventing Shortages in the Developed Countries
      • Financial incentives
      • Equitable pricing
      • Vaccine stockpiles
      • Preventing Shortages in Developing Nations
      • Vaccine bonds
    • PREVENTING PANDEMICS
      • U.S. National Vaccine Plan
    • VACCINES AND BIOTERRORISM
      • Overview
      • Project Bioshield Act
        • Table Selected Companies/Laboratories Developing Biodefense Vaccines
      • National Bio and Agro-Defense Facility
      • Vaccine Treatment and Evaluation Units
      • Anthrax
      • Smallpox
      • Tularemia
      • Viral Hemorrhagic Fevers
    • DTC ADVERTISING OF VACCINES
    • DNA VACCINATION
    • INNOVATIONS IN VACCINE DELIVERY SYSTEMS
      • Edible Vaccines
      • Mucosal Delivery
      • Intranasal Delivery
      • Vaccine Patches
      • Vaccine Chips
    • INNOVATIONS IN VACCINE PRODUCTION
      • Tobacco Plants
      • Insects
      • Nanoparticle Systems
      • Cloning
  • Company Profiles
    • ALPHAVAX, INC.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAVARIAN NORDIC A/S
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAXTER HEALTHCARE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BHARAT BIOTECH
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CELLDEX THERAPEUTICS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CRUCELL /JOHNSON & JOHNSON
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • EMERGENT BIOSOLUTIONS
      • History and Lines of Business
      • Strategic Acquisition and Alliance
      • Vaccine Products
      • Financial
    • GLAXOSMITHKLINE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MEDIMMUNE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MERCK & CO. INC
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • NABI BIOPHARMACEUTICALS
      • History and Lines of Business
      • Strategic Alliance
      • Vaccine Products
      • Financial Information
    • NOVARTIS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • PFIZER
      • History and Lines of Business
      • Strategic alliances
      • Vaccine Products
      • Financial Information
    • SANOFI PASTEUR
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report